An Interactive Association of Advanced Glycation End-Product Receptor Gene Four Common Polymorphisms with Coronary Artery Disease in Northeastern Han Chinese

PLoS ONE

Volumn 8, Issue 10, 2013, Pages

  Yu, Xiaohong ^a   Liu, Jun ^a   Zhu, Hao ^a   Xia, Yunlong ^a   Gao, Lianjun ^a   Li, Zhen ^a   Jia, Nan ^b   Shen, Weifeng ^b   Yang, Yanzong ^a   Niu, Wenquan ^b,c  

^a DALIAN MEDICAL UNIVERSITY   (China)

^b SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^c SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR;

ALLELE; AMINO ACID SUBSTITUTION; ANGIOCARDIOGRAPHY; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY RISK; DISEASE ASSOCIATION; FEMALE; GENE INTERACTION; GENE LOCUS; GENETIC POLYMORPHISM; HAPLOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIFACTOR DIMENSIONALITY REDUCTION; NUCLEIC ACID BASE SUBSTITUTION; PATHOGENESIS; RECEPTOR GENE; RISK ASSESSMENT; VALIDITY;

ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CHINA; CORONARY ARTERY DISEASE; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC LOCI; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; MIDDLE AGED; MULTIFACTOR DIMENSIONALITY REDUCTION; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; RISK FACTORS;

EID: 84885398348     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0076966     Document Type: Article

References (30)

1. Hegab Z, Gibbons S, Neyses L, Mamas MA, (2012) Role of advanced glycation end products in cardiovascular disease. World J Cardiol 4: 90-102.
2. Shrikhande GV, Scali ST, da Silva CG, Damrauer SM, Csizmadia E, et al. (2010) O-glycosylation regulates ubiquitination and degradation of the anti-inflammatory protein A20 to accelerate atherosclerosis in diabetic ApoE-null mice. PLoS One 5: e14240.
3. Pollreisz A, Hudson BI, Chang JS, Qu W, Cheng B, et al. (2010) Receptor for advanced glycation endproducts mediates pro-atherogenic responses to periodontal infection in vascular endothelial cells. Atherosclerosis 212: 451-456.
4. Ramasamy R, Yan SF, Schmidt AM, (2009) RAGE: therapeutic target and biomarker of the inflammatory response - the evidence mounts. J Leukoc Biol 86: 505-512.
5. Volz HC, Laohachewin D, Seidel C, Lasitschka F, Keilbach K, et al. (2012) S100A8/A9 aggravates post-ischemic heart failure through activation of RAGE-dependent NF-kappaB signaling. Basic Res Cardiol 107: 250.
6. Neeper M, Schmidt AM, Brett J, Yan SD, Wang F, et al. (1992) Cloning and expression of a cell surface receptor for advanced glycosylation end products of proteins. J Biol Chem 267: 14998-15004.
7. Falcone C, Emanuele E, D'Angelo A, Buzzi MP, Belvito C, et al. (2005) Plasma levels of soluble receptor for advanced glycation end products and coronary artery disease in nondiabetic men. Arterioscler Thromb Vasc Biol 25: 1032-1037.
8. Selejan SR, Poss J, Hewera L, Kazakov A, Bohm M, et al. (2012) Role of receptor for advanced glycation end products in cardiogenic shock. Crit Care Med 40: 1513-1522.
9. Park HJ, Baek JY, Shin WS, Kim DB, Jang SW, et al. (2011) Soluble receptor of advanced glycated endproducts is associated with plaque vulnerability in patients with acute myocardial infarction. Circ J 75: 1685-1690.
10. Cai XY, Lu L, Wang YN, Jin C, Zhang RY, et al. (2011) Association of increased S100B, S100A6 and S100P in serum levels with acute coronary syndrome and also with the severity of myocardial infarction in cardiac tissue of rat models with ischemia-reperfusion injury. Atherosclerosis 217: 536-542.
11. Gao J, Shao Y, Lai W, Ren H, Xu D, (2010) Association of polymorphisms in the RAGE gene with serum CRP levels and coronary artery disease in the Chinese Han population. J Hum Genet 55: 668-675.
12. Khanna M, Park P, Zirvi M, Cao W, Picon A, et al. (1999) Multiplex PCR/LDR for detection of K-ras mutations in primary colon tumors. Oncogene 18: 27-38.
13. Stram DO, Leigh Pearce C, Bretsky P, Freedman M, Hirschhorn JN, et al. (2003) Modeling and E-M estimation of haplotype-specific relative risks from genotype data for a case-control study of unrelated individuals. Hum Hered 55: 179-190.
14. Pattin KA, White BC, Barney N, Gui J, Nelson HH, et al. (2009) A computationally efficient hypothesis testing method for epistasis analysis using multifactor dimensionality reduction. Genet Epidemiol 33: 87-94.
15. Hahn LW, Ritchie MD, Moore JH, (2003) Multifactor dimensionality reduction software for detecting gene-gene and gene-environment interactions. Bioinformatics 19: 376-382.
16. Torres MC, Beltrame MH, Santos IC, Picheth G, Petzl-Erler ML, et al. (2012) Polymorphisms of the promoter and exon 3 of the receptor for advanced glycation end products (RAGE) in Euro- and Afro-Brazilians. Int J Immunogenet 39: 155-160.
17. Wang J, Zou L, Song Z, Lang X, Huang S, et al. (2012) Meta-analysis of RAGE gene polymorphism and coronary heart disease risk. PLoS One 7: e50790.
18. Evangelou E, Ioannidis JP, (2013) Meta-analysis methods for genome-wide association studies and beyond. Nat Rev Genet 14: 379-389.
19. Pineda-Krch M, Lehtila K, (2004) Costs and benefits of genetic heterogeneity within organisms. J Evol Biol 17: 1167-1177.
20. Kalea AZ, Schmidt AM, Hudson BI, (2009) RAGE: a novel biological and genetic marker for vascular disease. Clin Sci (Lond) 116: 621-637.
21. Laki J, Kiszel P, Vatay A, Blasko B, Kovacs M, et al. (2007) The HLA 8.1 ancestral haplotype is strongly linked to the C allele of -429T>C promoter polymorphism of receptor of the advanced glycation endproduct (RAGE) gene. Haplotype-independent association of the -429C allele with high hemoglobinA1C levels in diabetic patients. Mol Immunol 44: 648-655.
22. Gui J, Andrew AS, Andrews P, Nelson HM, Kelsey KT, et al. (2010) A simple and computationally efficient sampling approach to covariate adjustment for multifactor dimensionality reduction analysis of epistasis. Hum Hered 70: 219-225.
23. Niu WQ, Zhao HY, Zhou L, Dai XX, Wang DY, et al. (2009) Interacting effect of genetic variants of angiotensin II type 1 receptor on susceptibility to essential hypertension in Northern Han Chinese. J Hum Hypertens 23: 68-71.
24. Hudson BI, Stickland MH, Futers TS, Grant PJ, (2001) Effects of novel polymorphisms in the RAGE gene on transcriptional regulation and their association with diabetic retinopathy. Diabetes 50: 1505-1511.
25. Roy SW, Irimia M, (2008) Intron mis-splicing: no alternative? Genome Biol 9: 208.
26. Gu M, Dong X, Zhang X, Wang X, Qi Y, et al. (2012) Strong association between two polymorphisms on 15q25.1 and lung cancer risk: a meta-analysis. PLoS One 7: e37970.
27. Niu W, Liu Y, Qi Y, Wu Z, Zhu D, et al. (2012) Association of interleukin-6 circulating levels with coronary artery disease: a meta-analysis implementing mendelian randomization approach. Int J Cardiol 157: 243-252.
28. Niu W, Qi Y, (2012) Matrix metalloproteinase family gene polymorphisms and risk for coronary artery disease: systematic review and meta-analysis. Heart 98: 1483-1491.
29. Moore JH, Ritchie MD, (2004) STUDENTJAMA. The challenges of whole-genome approaches to common diseases. JAMA 291: 1642-1643.
30. Zintzaras E, Raman G, Kitsios G, Lau J, (2008) Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch Intern Med 168: 1077-1089.